Sign In
Buy KZR
Kezar Life Sciences Stock Insider Power
Based on the 100 latest insides trades, we have calculated the insider power to be negative at -64.98. In total, the insiders bought 359.79K and sold 826.62K KZR shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.
Insider Power
|
-64.98 |
| ● Buy | 359.79K shares |
| ● Sell | 826.62K shares |
|
37% Buy Activity
Weak Negative Correlation
|
|
Historical Insider Trades
| Date | Type | Person | Role | Amount |
|---|---|---|---|---|
|
Jun 18, 2025 Buy |
Garner Elizabeth Director |
5 000 Value: $22.3K |
||
|
Jun 18, 2025 Buy |
Wallace Courtney Director |
5 000 Value: $22.3K |
||
|
Jun 18, 2025 Buy |
Kauffman Michael Director |
5 000 Value: $22.3K |
||
|
Jun 18, 2025 Buy |
Klearman Micki Director |
5 000 Value: $22.3K |
||
|
Apr 01, 2025 Buy |
Chiang Pichi Luo SVP, Corporate Controller |
0 Value: $0 |
||
|
Apr 01, 2025 Buy |
Chiang Pichi Luo SVP, Corporate Controller |
7 999 Value: $182.4K |
||
|
Apr 01, 2025 Buy |
Chiang Pichi Luo SVP, Corporate Controller |
10 000 Value: $93.0K |
||
|
Apr 01, 2025 Buy |
Chiang Pichi Luo SVP, Corporate Controller |
7 500 Value: $47.3K |
||
|
Apr 01, 2025 Buy |
Chiang Pichi Luo SVP, Corporate Controller |
17 500 Value: $115.2K |
||
|
Apr 01, 2025 Buy |
To Zung Phoung SVP, Clinical Development |
25 000 Value: $765.0K |
||
|
Apr 01, 2025 Buy |
To Zung Phoung SVP, Clinical Development |
12 499 Value: $285.0K |
||
|
Apr 01, 2025 Buy |
To Zung Phoung SVP, Clinical Development |
10 000 Value: $63.0K |
||
|
Apr 01, 2025 Buy |
To Zung Phoung SVP, Clinical Development |
24 999 Value: $232.5K |
||
|
Apr 01, 2025 Buy |
To Zung Phoung SVP, Clinical Development |
20 000 Value: $131.6K |
||
|
Apr 01, 2025 Buy |
To Zung Phoung SVP, Clinical Development |
20 000 Value: $131.6K |
||
|
Apr 01, 2025 Buy |
To Zung Phoung SVP, Clinical Development |
24 999 Value: $232.5K |
||
|
Apr 01, 2025 Buy |
To Zung Phoung SVP, Clinical Development |
10 000 Value: $63.0K |
||
|
Apr 01, 2025 Buy |
To Zung Phoung SVP, Clinical Development |
12 499 Value: $285.0K |
||
|
Apr 01, 2025 Buy |
To Zung Phoung SVP, Clinical Development |
25 000 Value: $765.0K |
||
|
Apr 01, 2025 Buy |
Chiang Pichi Luo SVP, Corporate Controller |
17 500 Value: $115.2K |
||
|
Apr 01, 2025 Buy |
Chiang Pichi Luo SVP, Corporate Controller |
7 500 Value: $47.3K |
||
|
Apr 01, 2025 Buy |
Chiang Pichi Luo SVP, Corporate Controller |
10 000 Value: $93.0K |
||
|
Apr 01, 2025 Buy |
Chiang Pichi Luo SVP, Corporate Controller |
7 999 Value: $182.4K |
||
|
Apr 01, 2025 Buy |
Chiang Pichi Luo SVP, Corporate Controller |
0 Value: $0 |
||
|
Mar 27, 2025 Buy |
Schiller Mark C. Chief Legal Officer |
4 800 Value: $30.2K |
About Insider Power
Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.
It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.
While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.
* October 6th, 2025 - Tested on 5562 stocks
